Bavaria Clinic
SECTOR: Health, Pharmaceuticals and Biotechnology / Professional Services and Education
Registered Global Reach
AustriaUnited KingdomItalySpainEuropeGermany,
History of International Operations
| Date | Operation Summary | Key Figures / Investment | Destination Country |
|---|---|---|---|
| 2025-11-25 |
Clínica Baviera has exceeded €220 million in revenue, a 16% increase, driven by its international expansion and the integration of the acquired business in the United Kingdom. Its key markets include Spain, Germany, Austria, Italy, and the United Kingdom.
|
Consolidated revenues of €220M (+16%), net profit of €28,3M (+1%), and investment of €17,4M. | Spain, Germany, Austria, Italy, United Kingdom |
| 2025-11-25 |
Clínica Baviera has reported consolidated revenues of 220 million euros, up 16%, driven by its international business in Spain, Germany, Austria, Italy and the integration of its acquisition in the United Kingdom.
|
Consolidated revenue: €220 million (+16%). Net profit: €28,3 million (+1%). Investment: €17,4 million. | Spain, Germany, Austria, Italy, United Kingdom |
| 2025-07-29 |
Clínica Baviera reported a robust financial performance in the first half of 2025, with revenues of €154,7 million (+18%). It consolidated its leadership in Europe, investing €11,6 million in expansion and demonstrating growth in Spain, Germany, and Italy, following the acquisition of Optimax in the United Kingdom.
|
Revenue of 154,7 million euros (+18%), investment of 11,6 million euros, EBITDA of 44,5 million euros, net profit of 22,8 million euros. | United Kingdom, Spain, Germany, Italy |
| 2025-07-29 |
Clínica Baviera reported a robust financial performance in the first half of 2025, with revenues of 154,7 million euros and an investment of 11,6 million to expand its network of clinics in Europe, consolidating its leadership in the ophthalmological sector after the acquisition of Optimax in the United Kingdom.
|
Revenue of 154,7 million euros (+18%); Investment of 11,6 million euros; Consolidated EBITDA of 44,5 million euros (+6%); Net profit of 22,8 million euros. | Europe, United Kingdom, Spain, Germany, Italy |
| 2024-05-24 |
Clínica Baviera has reported an increase in its international revenue during the first quarter of 2024, with a turnover of 13,8 million euros in Germany and Austria, and 5,5 million euros in Italy, where EBITDA grew by 26%.
|
Revenue in Germany and Austria: €13,8 million. Revenue in Italy: €5,5 million. EBITDA increase in Italy: 26%. Total revenue: €66,4 million. Total EBITDA: €21,5 million. Net profit: €12,4 million. | Germany, Austria, Italy |
| 2023-07-25 |
Clínica Baviera has published its results for the first half of 2023, showing growth in revenue and net profit. The company has 101 clinics, 33 of which are in Germany (including Austria) and Italy, highlighting its international presence.
|
Revenue of €115,9 million, EBITDA of €37,3 million, net profit of €21,4 million, investment of €8,4 million. It has 101 of its own clinics, 26 in Germany/Austria and 7 in Italy. | Germany, Austria, Italy |
| 2023-02-28 |
Clínica Baviera continues its expansion in Spain, Germany and Italy, reaching 100 operating clinics and achieving record highs in sales (198,4 million euros) and net profit (30,1 million euros) in 2022.
|
Total sales €198,4 million, net profit €30,1 million. Turnover in Spain €140,7M, Germany €42,6M, Italy €15,1M. 100 operating clinics and 1.300 employees. | Spain, Germany, Italy |
| 2022-05-18 |
Clínica Baviera has obtained revenues of 52,4 million euros in the first quarter of 2022, 27,2% more than the previous year, with a net profit of 11,1 million euros, highlighting its growth in Spain, Germany, Austria and Italy.
|
Revenue of 52,4 million euros; EBITDA of 18,6 million euros; Net profit of 11,1 million euros; 92 clinics; 1.250 professionals; Investment of 1,9 million euros. | Spain, Germany, Austria, Italy |
Any questions about this news?
Talk to Coexia, the AI of the foreign trade
